News | May 29, 2023
Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated
